IMS Health: Pharma Should Make Better Use of Social Media To Engage Patients and Improve the Use of Medicines
Standard Social Media Practices Are Risky For Big Pharma – Law360

J&J, Glaxo are tops in social media, but smaller drugmakers rate highly, too

It’s no revelation that pharma is behind the curve when it comes to social media. Consider yourselves fortunate, then, that the IMS Institute for Healthcare Informatics chose to delve into the subject.